Nuveen Asset Management, LLC Merrimack Pharmaceuticals Inc Transaction History

Nuveen Asset Management, LLC

  • $345 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$12.02 - $13.07 $164,902 - $179,307
13,719 New
13,719 $168,000
Q3 2019

Nov 14, 2019
SELL
$4.16 - $6.05 $1.97 Million - $2.87 Million
-473,811 Closed
0 $0
Q2 2019

Aug 15, 2019
BUY
$4.39 - $5.66 $2.08 Million - $2.68 Million
473,811 New
473,811 $2.87 Million

Others Institutions Holding MACK

# of Institutions
2
Shares Held
349
Call Options Held
0
Put Options Held
0
View Full List

About MERRIMACK PHARMACEUTICALS INC

MACK Quotes by TradingView
  • Ticker MACK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,410,200
  • Market Cap $203M
  • Description
  • Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
More about MACK
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email